Papillectomy: Clinical Results

  • Alberto MarianiEmail author


Endoscopic papillectomy (EP) is a safe and effective first-line treatment for small tumors of the ampulla of Vater. EP may be considered as a curative treatment in case of ampullary adenoma with high-grade intraepithelial dysplasia or well-differentiated in situ tumor with negative resection margins. Predictors of long-term success (>85% of cases) include patient age >48 years, lesion size ≤24 mm, male sex, absence of polyposis syndrome, and intestinal histological subtype. Adverse events range from 10 to 35% and are successfully managed in most of the cases, sometimes after multidisciplinary evaluation. The incidence of residual/recurrent adenoma is high (about 40%), but it is balanced by the successful endoscopic re-treatment. Endoscopic surveillance is mandatory for identifying and managing residual/recurrent adenomatous tissue particularly if the surveillance intervals are not standardized.


Endoscopic papillectomy Ampullectomy Ampullary neoplasms Ampullary adenoma Endoscopic retrograde cholangiopancreatography 


  1. 1.
    El Hajj II, Coté GA. Endoscopic diagnosis and management of ampullary lesions. Gastrointest Endosc Clin N Am. 2013;23:95–109.CrossRefGoogle Scholar
  2. 2.
    Petrone G, Ricci R, Familiari P, Inzani F, Matsuoka M, Mutignani M, Delle Fave G, Costamagna G, Rindi G. Endoscopic snare papillectomy: a possible radical treatment for a subgroup of T1 ampullary adenocarcinomas. Endoscopy. 2013;45:401–4.CrossRefGoogle Scholar
  3. 3.
    Salmi S, Ezzedine S, Vitton V, Ménard C, Gonzales JM, Desjeux A, Grimaud JC, Barthet M. Can papillary carcinomas be treated by endoscopic ampullectomy? Surg Endosc. 2012;26(4):920–5.CrossRefGoogle Scholar
  4. 4.
    Kim H-K, Lo SK. Endoscopic approach to the patients with benign or malignant ampullary lesions. Gastrointest Endosc Clin N Am. 2013;23:347–83.CrossRefGoogle Scholar
  5. 5.
    Seewald S, Omar S, Soehendra N. Endoscopic resection of tumors of the ampulla of Vater: how far up and how deep down can we go? Gastrointest Endosc. 2006;63:789–91.CrossRefGoogle Scholar
  6. 6.
    Bohnacker S, Seitz U, Nguyen D, et al. Endoscopic resection of benign tumors of the duodenal papilla without and with intraductal growth. Gastrointest Endosc. 2005;62:551–60.CrossRefGoogle Scholar
  7. 7.
    Catalano MF, Linder JD, Chak A, et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc. 2004;59:225–32.CrossRefGoogle Scholar
  8. 8.
    Kahaleh M, Shami VM, Brock A, et al. Factors predictive of malignancy and endoscopic resectability in ampullary neoplasia. Am J Gastroenterol. 2004;99:2335–9.CrossRefGoogle Scholar
  9. 9.
    Irani S, Arai A, Ayub K, et al. Papillectomy for ampullary neoplasm: results of a single referral center over a 10-year period. Gastrointest Endosc. 2009;70:923–32.CrossRefGoogle Scholar
  10. 10.
    Onkendi EO, Naik ND, Rosedahl JK, Harmsen SW, Gostout CJ, Baron TH, Sarr MG, Que FG. Adenomas of the ampulla of Vater: a comparison of outcomes of operative and endoscopic resections. J Gastrointest Surg. 2014;18:1588–96.CrossRefGoogle Scholar
  11. 11.
    Napoleon B, Gincul R, Ponchon T, et al. Endoscopic papillectomy for early ampullary tumors: long-term results from a large multicentre prospective study. Endoscopy. 2014;46:127–34.CrossRefGoogle Scholar
  12. 12.
    Kang SH, Kim KH, Kim TN, et al. Therapeutic outcomes of endoscopic papillectomy for ampullary neoplasms: retrospective analysis of a multicenter study. BMC Gastroenterol. 2017;17:69–76.CrossRefGoogle Scholar
  13. 13.
    Valerij G, Tringali A, Bove V, Landi R, Barbaro F, Boskoski I, Familiari P, Perri V, Costamagna G. Endoscopic papillectomy: long-term results in 110 consecutive patients. Endoscopy. 2018;50(4):S68–9.Google Scholar
  14. 14.
    Kim JH, Han JH, Yoo BM, et al. Is endoscopic papillectomy safe for ampullary adenomas with high-grade dysplasia? Ann Surg Oncol. 2009;16:2547–54.CrossRefGoogle Scholar
  15. 15.
    Adsay V, Ohike N, Tajiri T, et al. Ampullary region carcinomas. Definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol. 2012;36:1592–608.CrossRefGoogle Scholar
  16. 16.
    Hyun JJ, Lee TH, Park JS, et al. Prospective multicenter study of submucosal injection to improve endoscopic snare papillectomy for ampullary adenoma. Gastrointest Endosc. 2017;85:746–55.CrossRefGoogle Scholar
  17. 17.
    Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc. 2005;62:367–70.CrossRefGoogle Scholar
  18. 18.
    Klein A, Qi Z, Bahin FF, et al. Outcomes after endoscopic resection of large laterally spreading lesions of the papilla and conventional ampullary adenomas are equivalent. Endoscopy. 2018;50:972–83.CrossRefGoogle Scholar
  19. 19.
    Zolotarevsky E, Fehmi SM, Anderson MA, et al. Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial. Endoscopy. 2011;43:325–30.CrossRefGoogle Scholar
  20. 20.
    Chathadi KV, Khashab MA, Acosta RD, et al. The role of endoscopy in ampullary and duodenal adenomas Prepared by: Asge Standards of Practice Committee. Gastrointest Endosc. 2015;82(5):773–81.CrossRefGoogle Scholar
  21. 21.
    Cheng CL, Sherman S, Fogel EL, et al. Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc. 2004;60:757–64.CrossRefGoogle Scholar
  22. 22.
    Patel R, Davitte J, Varadarajulu S, et al. Endoscopic resection of ampullary adenomas: complications and outcomes. Dig Dis Sci. 2011;56:3235–40.CrossRefGoogle Scholar
  23. 23.
    Camus M, Napoléon B, Vienne A, Marc LR, Leblanc S, Barret M, Chaussade S, Robin F, Kaddour N, Prat F. Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study. Gastrointest Endosc. 2018;88:511–8.CrossRefGoogle Scholar
  24. 24.
    Rustagi T, Irani S, Reddy DN, Abu Dayyeh BK, Baron TH, Gostout CJ, Levy MJ, Martin J, Petersen BT, Ross A, Topazian MD. Radiofrequency ablation for intraductal extension of ampullary neoplasms. Gastrointest Endosc. 2017;86(1):170–6.CrossRefGoogle Scholar
  25. 25.
    Mensah ET, Martin J, Topazian M. Radiofrequency ablation for biliary malignancies. Curr Opin Gastroenterol. 2016;32:238–43.PubMedGoogle Scholar
  26. 26.
    McCarty TR, Rustagi T. New indications for endoscopic radiofrequency ablation. Clin Gastroenterol Hepatol. 2018;16(7):1007–101.CrossRefGoogle Scholar
  27. 27.
    Chandrasekhara V, Topazian M. Biliary radiofrequency ablation: burning issues. Gastrointest Endosc. 2018;88(3):519–20.CrossRefGoogle Scholar
  28. 28.
    Nam K, Song TJ, Kim RE, Cho DH, Cho M, Oh O, Hyun Park D, Soo Lee S, Seo DW, Lee SK, Kim MH, Baek S. Usefulness of argon plasma coagulation ablation subsequent to endoscopic snare papillectomy for ampullary adenoma. Dig Endosc. 2018;30:485–92.CrossRefGoogle Scholar
  29. 29.
    Panzeri F, Crippa S, Castelli P, Aleotti F, Pucci A, Partelli S, Zamboni G, Falconi M. Management of ampullary neoplasms: a tailored approach between endoscopy and surgery. World J Gastroenterol. 2015;21(26):7970–87.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Pancreato-Biliary Endoscopy and Endosonography DivisionPancreas Translational and Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita Salute San Raffaele UniversityMilanItaly

Personalised recommendations